Intas Pharma

Premium

Healthcare

11 October, 2022

CCI clears Adia investment in Intas Pharmaceuticals

The Competition Commission of India on Monday approved Singapore’s state investment arm Temasek’s move to sell a 3% stake in ......

Healthcare

09 October, 2018

Chronic therapies to drive PE investments in pharma: IQVIA report

Chronic therapies and oncology in particular will be among the key drivers of private equity investments in the Indian pharmaceuticals ......

General

10 October, 2016

Weekly Deals Tracker: Intas, Adani in large M&As; Argand, Everstone top PE charts

The week saw three large M&A deals led by the first acquisition of a British unit by an Indian company ......